Letter to the Editor
Chlamydia pneumoniae and Metabolic Syndrome
Abstract
To the Editor:
I read the recent original report by Lin et al1 on Chlamydia pneumoniaeand metabolic syndrome (MeS) with a great interest. Lin et al1concluded that “there is a positive association between C pneumoniaeseropositivity and MeS, which supports the role of infection in the pathogenesis of atherosclerosis and cardiovascular disease.” Indeed, the relationship between C pneumoniae and MeS is still a myth. Recently, Ebrahimi et al2 reported that high sensitivity C-reactive protein (CRP), a part of a combination “chronic infection and elevated CRP” that correlated with electrocardiogram-defined CAD, was associated with the MeS independent to viral and bacterial pathogen burden.3 In addition, due to the nature of the neoindustrialized developing country of Taiwan, the high prevalence of both Mes and metabolic syndrome can be expected. Whether C pneumoniae has direct correlation to Mes, or is only a cofinding, has to be further verified.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.